Journals / Mucosa / 2018 / Cilt: 1 - Sayı: 2

Gut microbiata: underestimated or exaggerated?

Bağırsak mikrobiyotası: küçümsenmiş mi, abartılı mı?

Journal
Mucosa
Pages
30–35
Publication Date
2018-10-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Probably further high quality scientific research will determine the exact place of microbiota and probiotics in human health in the future.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Human gastrointestinal tract contains a large diversity of commensal microorganisms, which is many times more than the human living cells.
📊
Key Findings & Data:There is a clear increase in the number of pathological conditions associated with dysbiosis in time.
💡
Conclusion & Impact:Probably further high quality scientific research will determine the exact place of microbiota and probiotics in human health in the future.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Bağırsak mikrobiyotası · probiyotikler · Gut microbiata

Abstract

Human gastrointestinal tract contains a large diversity of commensal microorganisms, which is many times more than the human living cells. In the last decade, we had enormous number of research on the association with diseases and gut microbiota composition. There is a clear increase in the number of pathological conditions associated with dysbiosis in time. Also, the range of diseases are increased and distributed to many disciplines, non-gastrointestinal diseases are also increasingly reported. Gut microbiota has multiple functions and new applications for diagnosis and therapeutics of diseases. Probiotics are widely used in health and disease states. Probably further high quality scientific research will determine the exact place of microbiota and probiotics in human health in the future.

Özet

İnsan gastrointestinal sistemi, tüm insan hücrelerinee göre çok daha fazla sayıda ve büyük bir çeşitlilikteki komensal mikroorganizmaları içerir. Son on yılda, bağırsak mikrobiyotasının içeriği ve hastalıkların ilişkisi üzerine çok fazla sayıda araştırma yaptık. Zaman içinde disbiyoz ile ilişkili patolojik durumların sayısında belirgin bir artış olmuştur. Ayrıca, bu hastalıkların yelpazesi daha da genişlemiş ve birçok disipline dağılmıştır. Gastrointestinal hastalıklar dışındakiler giderek daha fazla rapor edilir olmuştur. Bağırsak mikrobiyatası birçok fonksiyona sahip olmanın yanında hastalıkların tanı ve tedavisi için da birçok yeni uygulamaya sahiptir. Probiyotikler, hastalık ve sağlıkta yaygın olarak kullanılmaktadır. Yüksek kaliteli bilimsel araştırmalar, gelecekte, mikrobiyota ve probiyotiklerin insan sağlığı üzerindeki gerçek yerini belirleyecektir.

🔖

Cite This Article

KARAKAN, T. (2018). Gut microbiata: underestimated or exaggerated?. Mucosa, Cilt: 1 - Sayı: 2, 30–35. https://ajindex.com/articles/840063

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, Knight R. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A. 2010;107:11971–5
  2. Tanaka S, Kobayashi T, Songjinda P, Tateyama A, Tsubouchi M, Kiyohara C, Shirakawa T, Sonomoto K, Nakayama J. Influence of antibiotic exposure in the early postnatal period on the development of intestinal microbiota. FEMS Immunol Med Microbiol. 2009;56:80–7
  3. Salminen S, Gibson GR, McCartney AL, Isolauri E. Influence of mode of delivery on gut microbiota composition in seven year old children. Gut. 2004;53:1388–9
  4. Makino H, Kushiro A, Ishikawa E, Kubota H, Gawad A, Sakai T, Oishi K, Martin R, Ben-Amor K, Knol J, Tanaka R. Mother-to-infant transmission of intestinal bifidobacterial strains has an impact on the early development of vaginally delivered infant’s microbiota. PLoS One 2013;8:e78331
  5. Munyaka PM, Khafipour E, Ghia JE. External influence of early childhood establishment of gut microbiota and subsequent health implications. Front Pediatr 2014;2:109
  6. Sender R, Fuchs S, Milo R. Revised Estimates for the number of human and bacteria cells in the body. PLoS Biol 2016; 14: 8: e1002533
  7. Flint HJ, Scott KP, Louis P, Duncan SH. The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol 2012;9:577–589
  8. Oleskin AV, Shenderov BA. Neuromodulatory effects and targets of the SCFAs and gasotransmitters produced by the human symbiotic microbiota. Microb Ecol Health Dis 2016; 27:30971
  9. Food and Agriculture Organization of the United Nations and World Health Organization. Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. Geneva, Switz: Food and Agriculture Organization of the United Nations and World Health Organization Expert Consultation Report; 2001. [cited 2005 September 13]
  10. Guarner F, Khan AG, Garisch J, Eliakim R, Gangl A, Thomson A, Krabshuis J, Lemair T, Kaufmann P, de Paula JA, Fedorak R, Shanahan F, Sanders ME, Szajewska H, Ramakrishna BS, Karakan T, Kim N; World Gastroenterology Organization. World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011. J Clin Gastroenterol. 2012 Jul;46:468-81
  11. Grossi E, Buresta R, Abbiati R, Cerutti R, Pro-DIA study group. Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with acute diarrhea: a multicent